Publications and Presentations

Review our key scientific publications/presentations featuring our OncoHist technology.

Publications

A Phase I/II dose escalation trial of OncoHist (recombinant human histone H1-3) in patients with relapsed or refractory acute myeloid leukemia OncoHist inhibits survival leukaemia cells

PDF

Oncohist inhibits survival leukaemia cells

PDF